

Half of long COVID patients see significant improvement within three years, with over a quarter...

Breast bruises may not always be harmless, as they can sometimes be a sign of...

A UCSF study links autoantibodies to preterm birth risk, identifying antibodies that may trigger early...
Read our latest Germ Control articles.

Cefiderocol exhibits improved in vitro activity against multidrug-resistant Gram-negative pathogens at IDWeek 2026, with MICs...

Living with polycythemia vera requires balance and paying attention to body cues to avoid overexertion.

polycythemia vera treatment path explained: doctors detail first-line therapeutic phlebotomy and medication timing to help...

Half of long COVID patients see significant improvement within three years, with over a quarter experiencing complete remission of symptoms.




Half of long COVID patients see significant improvement within three years, with over a quarter experiencing complete remission of symptoms.
Labcorp's new hepatitis D testing reflex option aims to close the diagnostic gap, targeting U.S. hepatitis B patients where only...
New study reveals ceftobiprole’s nearly full effectiveness against MRSA in the first US surveillance results since FDA approval, with key...
Cefiderocol exhibits improved in vitro activity against multidrug-resistant Gram-negative pathogens at IDWeek 2026, with MICs decreasing by factors of 4...
Living with polycythemia vera requires balance and paying attention to body cues to avoid overexertion.
polycythemia vera treatment path explained: doctors detail first-line therapeutic phlebotomy and medication timing to help patients plan care.
New treatments improve breast cancer outlook for patients with hormone receptor-positive breast cancer, offering more ways to control the disease.
A 2024 study in Frontiers in Oncology finds 15-20% endometrial cancer recurrence risk after treatment, varying by patient factors.
Breast bruises may not always be harmless, as they can sometimes be a sign of cancer, requiring medical evaluation if...
Experts explain how patients and care teams can adapt after a myeloma relapse, addressing treatment strategies and managing expectations.